Letter by Micheletti and Chevallier regarding article, "Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER Study"

Circulation. 2007 Sep 25;116(13):e362; author reply e363. doi: 10.1161/CIRCULATIONAHA.107.709899.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / statistics & numerical data
  • Confidence Intervals
  • Estrogen Replacement Therapy / adverse effects*
  • Estrogens / administration & dosage
  • Estrogens / adverse effects
  • Female
  • Humans
  • Megestrol / administration & dosage
  • Megestrol / adverse effects*
  • Middle Aged
  • Norpregnadienes / administration & dosage
  • Norpregnadienes / adverse effects*
  • Norpregnanes / administration & dosage
  • Norpregnanes / adverse effects
  • Odds Ratio
  • Postmenopause
  • Progestins / administration & dosage
  • Progestins / adverse effects
  • Thromboembolism / chemically induced*
  • Venous Thrombosis / chemically induced*

Substances

  • Estrogens
  • Norpregnadienes
  • Norpregnanes
  • Progestins
  • nomegestrol acetate
  • Megestrol